Art Baker currently serves as the Vice President of Finance at Syapse, a pioneering healthcare technology company committed to transforming the management of serious diseases through data-driven insights and innovative solutions. In his role, Art leads the Financial Planning and Analysis (FP&A) group, where he...
Art Baker currently serves as the Vice President of Finance at Syapse, a pioneering healthcare technology company committed to transforming the management of serious diseases through data-driven insights and innovative solutions. In his role, Art leads the Financial Planning and Analysis (FP&A) group, where he is instrumental in shaping the company’s financial strategy. His responsibilities include meticulous planning, forecasting, and conducting ad-hoc analyses that inform critical business decisions. Art's expertise in developing complex financial models allows him to predict revenue streams, assess profitability, and evaluate cash runway and fundraising requirements, ensuring that Syapse remains well-positioned for sustainable growth.
With a robust background in corporate development and finance, Art has successfully navigated the complexities of mergers and acquisitions, having played a pivotal role in over 15 successful transactions throughout his career. His experience at RBC Capital Markets as an investment banker has equipped him with a deep understanding of valuation and negotiation, skills that are essential in the fast-evolving healthcare technology landscape. At Syapse, Art not only provides insightful reporting and analysis to the Board of Directors and C-Suite executives but also leverages his leadership capabilities to guide finance teams in aligning their objectives with the company’s mission of alleviating the burden of serious diseases.
Art’s diverse expertise extends beyond traditional finance; he has also been involved in launching innovative ventures such as Maven and GIG car share, showcasing his ability to adapt and thrive in emerging markets. His comprehensive skill set, which includes P&L review, MD&A, and business development, positions him as a key player in driving Syapse’s financial health and strategic initiatives, ultimately contributing to the company's vision of improving patient outcomes through advanced technology.
